Modified Release Coatings Market Size – Industry Structure Evaluation, Demand Drivers Analysis, Regional Growth Analysis and Identification, Competitive Positioning Review & Global Market Size Forecast to 2019

7.23%
CAGR (2020-2027)
N/A
Market Size
326
Report Pages
142
Market Tables

Overview

Global Modified Release Coatings Market was valued US$ XX.50 Bn and is expected to reach XX.46 Bn by 2027, at a CAGR of 7.23% during the forecast period.

Global Modified Release Coatings Market

To know about the Research Methodology :- Request Free Sample Report

Demand for the effective coating across the globe and huge growth in the pharmaceutical industries are considered as supportive market for the market growth; roughly 40 to 45% of market share is acquired by tablet coating sector.

Global Modified Release Coatings Market Definition:

Modified release coating isdefined as an advanced technology in the pharmaceutical coating sector in order to modify the action of active drug when released and engrossed into the body. Coating can be applied directly on the substrate or else by providing coating to the small capsules before compression process.

The report study has analyzed the revenue impact of COVID-19 pandemic on the sales revenue of market leaders, market followers, and disrupters in the report, and the same is reflected in our analysis.

Global Modified Release Coatings Market Drivers and Restraints:

Technological advancement and development in method of manufacturing process in developed and developing countries are driving the growth of modified release coatings market globally. Modified Release Coatings have broad application in the coating of tablet, capsules, pill expected to increase the market demand in near future. Machinery manufacturing process and increasing disposable income, rapid urbanization and established healthcare sector have managed to increase modified released related product amongst the growing population and is is estimated to boost up the modified release coatingsmarket.

Similarly,healthy evolution of the polymeric sector is also assessed to drive the modified release coatingsmarket. Also, availability of type as per patient suitability such as sustain release and enteric coating to provide targeted drug delivery application for the treatment of saviour diseases expected to record noticeable growth, huge growth in the paediatric and geriatric patients where modified release processis broadly utilised and covering market value with significant growth of US$ XX Bn. In terms of market share Asia Pacific was valued US$ XX Bn with considerable CAGR of XX%. Major key vendors are investing in modified release coatings market as this market is expected to show constant growth.

Additionally, upsurge in the request for the microencapsulated biomolecules is growing in the pharmaceutical industry owing to the huge requirement for targeted drug delivery system. Hence, the expansionin the drugs required for these applications are estimated to lift the request for modified release coatings for effective and targeted delivery of API. These are widelyused by pharmaceutical companies tocover the unpleasant taste andodour of drugs
However, limitations of raw materials and highmanufacturingcost negatively influence the modified release coatings market growth.

Global Modified Release Coatings Market Segment analysis:

By type segment, sustainedmodified coating sub segment is expected to dominate the modified release coatings market during the forecast years. Available large chain for the business will require high amount of modified release coatings, is expected to help the market growth. Furthermore, existing verity of mode of administration like in vitro and in vivo methods has promotedtargeted market growth.

The newer, high-growth substrate of sustained modified coatings such as capsule, pills and tablets. On the other hand, huge growth in the demand for the tablet which is showing constant support owing to ease of application and introduction of new API in the pharmaceutical drug applications.The targeted segment market is likely to be valued at approximately US$ X.4 Bn in 2019, owing to the increasing consumer demand, Virtually, 45% of market is acquired by sustained modifies segment.

Global Modified Release Coatings Market Regional Analysis:

Regionally, APAC is expected to dominate the modified release coatings market with an expected CAGR of XX % during the forecast period. Advancement in machinery in Asia Pacific region is boosting the market growth, especially India and Chinaare documented as major contributors. In 2019 market size was valued US$ XX Bn while in India market size was valued US$ XX Bn and expected to increase by US$ XX Bn in coming years.In 2019, approximately 40% of market is acquired by Asia Pacific region and expected to grow constantly in future.

Asia Pacific is followed by North America. North America is forecasted to show good growth owing to expandingawareness in microencapsulated tablets, and pills considered as major driving factor with advanced healthcare industry present in the region.

The objective of the report is to present a comprehensive analysis of theGlobalModified Release Coatings Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analysed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding Global Modified Release Coatings Market dynamics, structure by analysing the market segments and project the Global Modified Release Coatings Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Modified Release Coatings Market make the report investor’s guide.

Scope of Modified Release Coatings Market: Inquire before buying

Global Modified Release Coatings Market, By Polymer Type

• Polyvinyl & Cellulose Acetate
• Polyethylene Glycol (PEG)
• Ethyl & Methyl Cellulose
• Methacrylic Acid
• Others

Global Modified Release Coatings Market, By Substrate Type

• Tablets
• Capsules
• Pills

Global Modified Release Coatings Market, ByType

• Sustained Modified Coatings
• Enteric Coatings

Global Modified Release Coatings Market, By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players Operating the Modified Release Coatings Market,

• Teva Pharmaceutical Industries Ltd
• Valeant Pharmaceuticals International, Inc
• Sun Pharmaceutical Industries Ltd
• Evonik Industries AG
• Coating Place, Inc
• GlaxoSmithKline plc
• Corium International, Inc
• Orbis Biosciences, Inc
• Mylan N.V
• Pfizer, Inc
• Evonik
• Colorcon
• BASF SE
• Novartis AG
• AstraZeneca
• Depomed, Inc

Table of Contents

Global Modified Release Coatings Market

1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Metal Surface Treatment Chemical Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Modified Release Coatings Market Analysis and Forecast 6.1. Modified Release Coatings Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Modified Release Coatings Analysis and Forecast, By Polymer Type 7.1. Introduction and Definition 7.2. Key Findings 7.3. Modified Release Coatings Value Share Analysis, By Polymer Type 7.4. Modified Release Coatings Size (US$ Bn) Forecast, By Polymer Type 7.5. Modified Release Coatings Analysis, By Polymer Type 7.6. Modified Release Coatings Attractiveness Analysis, By Polymer Type 8. Global Modified Release Coatings Analysis and Forecast, By Substrate Type 8.1. Introduction and Definition 8.2. Key Findings 8.3. Modified Release Coatings Value Share Analysis, By Substrate Type 8.4. Modified Release Coatings Size (US$ Bn) Forecast, By Substrate Type 8.5. Modified Release Coatings Analysis, By Substrate Type 8.6. Modified Release Coatings Attractiveness Analysis, By Substrate Type 9. Global Modified Release Coatings Analysis and Forecast, By Type 9.1. Introduction and Definition 9.2. Key Findings 9.3. Modified Release Coatings Value Share Analysis, By Type 9.4. Modified Release Coatings Size (US$ Bn) Forecast, By Type 9.5. Modified Release Coatings Analysis, By Type 9.6. Modified Release Coatings Attractiveness Analysis, By Type 10. Global Modified Release Coatings Analysis, by Region 10.1. Modified Release Coatings Value Share Analysis, by Region 10.2. Modified Release Coatings Size (US$ Bn) Forecast, by Region 10.3. Modified Release Coatings Attractiveness Analysis, by Region 11. North America Modified Release Coatings Analysis 11.1. Key Findings 11.2. North America Modified Release Coatings Overview 11.3. North America Modified Release Coatings Value Share Analysis, By Polymer Type 11.4. North America Modified Release Coatings Forecast, By Polymer Type 11.4.1. Polyvinyl & Cellulose Acetate 11.4.2. Polyethylene Glycol (PEG) 11.4.3. Ethyl & Methyl Cellulose 11.4.4. Methacrylic Acid 11.4.5. Others 11.5. North America Modified Release Coatings Value Share Analysis, By Substrate Type 11.6. North America Modified Release Coatings Forecast, By Substrate Type 11.6.1. Tablets 11.6.2. Capsules 11.6.3. Pills 11.7. North America Modified Release Coatings Value Share Analysis, By Type 11.8. North America Modified Release Coatings Forecast, By Type 11.8.1. Sustained Modified Coatings 11.8.2. Enteric Coatings 11.9. North America Modified Release Coatings Value Share Analysis, by Country 11.10. North America Modified Release Coatings Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Modified Release Coatings Analysis, by Country 11.12. U.S. Modified Release Coatings Forecast, By Polymer Type 11.12.1. Polyvinyl & Cellulose Acetate 11.12.2. Polyethylene Glycol (PEG) 11.12.3. Ethyl & Methyl Cellulose 11.12.4. Methacrylic Acid 11.12.5. Others 11.13. U.S. Modified Release Coatings Forecast, By Substrate Type 11.13.1. Tablets 11.13.2. Capsules 11.13.3. Pills 11.14. U.S. Modified Release Coatings Forecast, By Type 11.14.1. Sustained Modified Coatings 11.14.2. Enteric Coatings 11.15. Canada Modified Release Coatings Forecast, By Polymer Type 11.15.1. Polyvinyl & Cellulose Acetate 11.15.2. Polyethylene Glycol (PEG) 11.15.3. Ethyl & Methyl Cellulose 11.15.4. Methacrylic Acid 11.15.5. Others 11.16. Canada Modified Release Coatings Forecast, By Substrate Type 11.16.1. Tablets 11.16.2. Capsules 11.16.3. Pills 11.17. Canada Modified Release Coatings Forecast, By Type 11.17.1. Sustained Modified Coatings 11.17.2. Enteric Coatings 11.18. North America Modified Release Coatings Attractiveness Analysis 11.18.1. By Polymer Type 11.18.2. By Substrate Type 11.18.3. By Type 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Developments 12. Europe Modified Release Coatings Analysis 12.1. Key Findings 12.2. Europe Modified Release Coatings Overview 12.3. Europe Modified Release Coatings Value Share Analysis, By Polymer Type 12.4. Europe Modified Release Coatings Forecast, By Polymer Type 12.4.1. Polyvinyl & Cellulose Acetate 12.4.2. Polyethylene Glycol (PEG) 12.4.3. Ethyl & Methyl Cellulose 12.4.4. Methacrylic Acid 12.4.5. Others 12.5. Europe Modified Release Coatings Value Share Analysis, By Substrate Type 12.6. Europe Modified Release Coatings Forecast, By Substrate Type 12.6.1. Tablets 12.6.2. Capsules 12.6.3. Pills 12.7. Europe Modified Release Coatings Value Share Analysis, By Type 12.8. Europe Modified Release Coatings Forecast, By Type 12.8.1. Sustained Modified Coatings 12.8.2. Enteric Coatings 12.9. Europe Modified Release Coatings Value Share Analysis, by Country 12.10. Europe Modified Release Coatings Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Norway 12.10.7. Russia 12.10.8. Rest of Europe 12.11. Europe Modified Release Coatings Analysis, by Country 12.12. Germany Modified Release Coatings Forecast, By Polymer Type 12.12.1. Polyvinyl & Cellulose Acetate 12.12.2. Polyethylene Glycol (PEG) 12.12.3. Ethyl & Methyl Cellulose 12.12.4. Methacrylic Acid 12.12.5. Others 12.13. Germany Modified Release Coatings Forecast, By Substrate Type 12.13.1. Tablets 12.13.2. Capsules 12.13.3. Pills 12.14. Germany Modified Release Coatings Forecast, By Type 12.14.1. Sustained Modified Coatings 12.14.2. Enteric Coatings 12.15. U.K. Modified Release Coatings Forecast, By Polymer Type 12.15.1. Polyvinyl & Cellulose Acetate 12.15.2. Polyethylene Glycol (PEG) 12.15.3. Ethyl & Methyl Cellulose 12.15.4. Methacrylic Acid 12.15.5. Others 12.16. U.K. Modified Release Coatings Forecast, By Substrate Type 12.16.1. Tablets 12.16.2. Capsules 12.16.3. Pills 12.17. U.K. Modified Release Coatings Forecast, By Type 12.17.1. Sustained Modified Coatings 12.17.2. Enteric Coatings 12.18. France Modified Release Coatings Forecast, By Polymer Type 12.18.1. Polyvinyl & Cellulose Acetate 12.18.2. Polyethylene Glycol (PEG) 12.18.3. Ethyl & Methyl Cellulose 12.18.4. Methacrylic Acid 12.18.5. Others 12.19. France Modified Release Coatings Forecast, By Substrate Type 12.19.1. Tablets 12.19.2. Capsules 12.19.3. Pills 12.20. France Modified Release Coatings Forecast, By Type 12.20.1. Sustained Modified Coatings 12.20.2. Enteric Coatings 12.21. Italy Modified Release Coatings Forecast, By Polymer Type 12.21.1. Polyvinyl & Cellulose Acetate 12.21.2. Polyethylene Glycol (PEG) 12.21.3. Ethyl & Methyl Cellulose 12.21.4. Methacrylic Acid 12.21.5. Others 12.22. Italy Modified Release Coatings Forecast, By Substrate Type 12.22.1. Tablets 12.22.2. Capsules 12.22.3. Pills 12.23. Italy Modified Release Coatings Forecast, By Type 12.23.1. Sustained Modified Coatings 12.23.2. Enteric Coatings 12.24. Spain Modified Release Coatings Forecast, By Polymer Type 12.24.1. Polyvinyl & Cellulose Acetate 12.24.2. Polyethylene Glycol (PEG) 12.24.3. Ethyl & Methyl Cellulose 12.24.4. Methacrylic Acid 12.24.5. Others 12.25. Spain Modified Release Coatings Forecast, By Substrate Type 12.25.1. Tablets 12.25.2. Capsules 12.25.3. Pills 12.26. Spain Modified Release Coatings Forecast, By Type 12.26.1. Sustained Modified Coatings 12.26.2. Enteric Coatings 12.27. NorwayModified Release Coatings Forecast, By Polymer Type 12.27.1. Polyvinyl & Cellulose Acetate 12.27.2. Polyethylene Glycol (PEG) 12.27.3. Ethyl & Methyl Cellulose 12.27.4. Methacrylic Acid 12.27.5. Others 12.28. Norway Modified Release Coatings Forecast, By Substrate Type 12.28.1. Tablets 12.28.2. Capsules 12.28.3. Pills 12.29. Norway Modified Release Coatings Forecast, By Type 12.29.1. Sustained Modified Coatings 12.29.2. Enteric Coatings 12.30. RussiaModified Release Coatings Forecast, By Polymer Type 12.30.1. Polyvinyl & Cellulose Acetate 12.30.2. Polyethylene Glycol (PEG) 12.30.3. Ethyl & Methyl Cellulose 12.30.4. Methacrylic Acid 12.30.5. Others 12.31. Russia Modified Release Coatings Forecast, By Substrate Type 12.31.1. Tablets 12.31.2. Capsules 12.31.3. Pills 12.32. Russia Modified Release Coatings Forecast, By Type 12.32.1. Sustained Modified Coatings 12.32.2. Enteric Coatings 12.33. Rest of Europe Modified Release Coatings Forecast, By Polymer Type 12.33.1. Polyvinyl & Cellulose Acetate 12.33.2. Polyethylene Glycol (PEG) 12.33.3. Ethyl & Methyl Cellulose 12.33.4. Methacrylic Acid 12.33.5. Others 12.34. Rest of Europe Modified Release Coatings Forecast, By Substrate Type 12.34.1. Tablets 12.34.2. Capsules 12.34.3. Pills 12.35. Rest of Europe Modified Release Coatings Forecast, By Type 12.35.1. Sustained Modified Coatings 12.35.2. Enteric Coatings 12.36. Europe Modified Release Coatings Attractiveness Analysis 12.36.1. By Polymer Type 12.36.2. By Substrate Type 12.36.3. By Type 12.37. PEST Analysis 12.38. Key Trends 12.39. Key Developments 13. Asia Pacific Modified Release Coatings Analysis 13.1. Key Findings 13.2. Asia Pacific Modified Release Coatings Overview 13.3. Asia Pacific Modified Release Coatings Value Share Analysis, By Polymer Type 13.4. Asia Pacific Modified Release Coatings Forecast, By Polymer Type 13.4.1. Polyvinyl & Cellulose Acetate 13.4.2. Polyethylene Glycol (PEG) 13.4.3. Ethyl & Methyl Cellulose 13.4.4. Methacrylic Acid 13.4.5. Others 13.5. Asia Pacific Modified Release Coatings Value Share Analysis, By Substrate Type 13.6. Asia Pacific Modified Release Coatings Forecast, By Substrate Type 13.6.1. Tablets 13.6.2. Capsules 13.6.3. Pills 13.7. Asia Pacific Modified Release Coatings Value Share Analysis, By Type 13.8. Asia Pacific Modified Release Coatings Forecast, By Type 13.8.1. Sustained Modified Coatings 13.8.2. Enteric Coatings 13.9. Asia Pacific Modified Release Coatings Value Share Analysis, by Country 13.10. Asia Pacific Modified Release Coatings Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. South Korea 13.10.5. Australia 13.10.6. Malaysia 13.10.7. Indonesia 13.10.8. Rest of Asia Pacific 13.11. Asia Pacific Modified Release Coatings Analysis, by Country 13.12. China Modified Release Coatings Forecast, By Polymer Type 13.12.1. Polyvinyl & Cellulose Acetate 13.12.2. Polyethylene Glycol (PEG) 13.12.3. Ethyl & Methyl Cellulose 13.12.4. Methacrylic Acid 13.12.5. Others 13.13. China Modified Release Coatings Forecast, By Substrate Type 13.13.1. Tablets 13.13.2. Capsules 13.13.3. Pills 13.14. China Modified Release Coatings Forecast, By Type 13.14.1. Sustained Modified Coatings 13.14.2. Enteric Coatings 13.15. India Modified Release Coatings Forecast, By Polymer Type 13.15.1. Polyvinyl & Cellulose Acetate 13.15.2. Polyethylene Glycol (PEG) 13.15.3. Ethyl & Methyl Cellulose 13.15.4. Methacrylic Acid 13.15.5. Others 13.16. India Modified Release Coatings Forecast, By Substrate Type 13.16.1. Tablets 13.16.2. Capsules 13.16.3. Pills 13.17. India Modified Release Coatings Forecast, By Type 13.17.1. Sustained Modified Coatings 13.17.2. Enteric Coatings 13.18. Japan Modified Release Coatings Forecast, By Polymer Type 13.18.1. Polyvinyl & Cellulose Acetate 13.18.2. Polyethylene Glycol (PEG) 13.18.3. Ethyl & Methyl Cellulose 13.18.4. Methacrylic Acid 13.18.5. Others 13.19. Japan Modified Release Coatings Forecast, By Substrate Type 13.19.1. Tablets 13.19.2. Capsules 13.19.3. Pills 13.20. Japan Modified Release Coatings Forecast, By Type 13.20.1. Sustained Modified Coatings 13.20.2. Enteric Coatings 13.21. South KoreaModified Release Coatings Forecast, By Polymer Type 13.21.1. Polyvinyl & Cellulose Acetate 13.21.2. Polyethylene Glycol (PEG) 13.21.3. Ethyl & Methyl Cellulose 13.21.4. Methacrylic Acid 13.21.5. Others 13.22. South Korea Modified Release Coatings Forecast, By Substrate Type 13.22.1. Tablets 13.22.2. Capsules 13.22.3. Pills 13.23. South Korea Modified Release Coatings Forecast, By Type 13.23.1. Sustained Modified Coatings 13.23.2. Enteric Coatings 13.24. AustraliaModified Release Coatings Forecast, By Polymer Type 13.24.1. Polyvinyl & Cellulose Acetate 13.24.2. Polyethylene Glycol (PEG) 13.24.3. Ethyl & Methyl Cellulose 13.24.4. Methacrylic Acid 13.24.5. Others 13.25. Australia Modified Release Coatings Forecast, By Substrate Type 13.25.1. Tablets 13.25.2. Capsules 13.25.3. Pills 13.26. Australia Modified Release Coatings Forecast, By Type 13.26.1. Sustained Modified Coatings 13.26.2. Enteric Coatings 13.27. MalaysiaModified Release Coatings Forecast, By Polymer Type 13.27.1. Polyvinyl & Cellulose Acetate 13.27.2. Polyethylene Glycol (PEG) 13.27.3. Ethyl & Methyl Cellulose 13.27.4. Methacrylic Acid 13.27.5. Others 13.28. Malaysia Modified Release Coatings Forecast, By Substrate Type 13.28.1. Tablets 13.28.2. Capsules 13.28.3. Pills 13.29. Malaysia Modified Release Coatings Forecast, By Type 13.29.1. Sustained Modified Coatings 13.29.2. Enteric Coatings 13.30. IndonesiaModified Release Coatings Forecast, By Polymer Type 13.30.1. Polyvinyl & Cellulose Acetate 13.30.2. Polyethylene Glycol (PEG) 13.30.3. Ethyl & Methyl Cellulose 13.30.4. Methacrylic Acid 13.30.5. Others 13.31. Indonesia Modified Release Coatings Forecast, By Substrate Type 13.31.1. Tablets 13.31.2. Capsules 13.31.3. Pills s 13.32. Indonesia Modified Release Coatings Forecast, By Type 13.32.1. Sustained Modified Coatings 13.32.2. Enteric Coatings 13.33. Rest of Asia Pacific Modified Release Coatings Forecast, By Substrate Type 13.33.1. Tablets 13.33.2. Capsules 13.33.3. Pills 13.34. Rest of Asia Pacific Modified Release Coatings Forecast, By Type 13.34.1. Sustained Modified Coatings 13.34.2. Enteric Coatings 13.35. Asia Pacific Modified Release Coatings Attractiveness Analysis 13.35.1. By Polymer Type 13.35.2. By Substrate Type 13.35.3. By Type 13.36. PEST Analysis 13.37. Key Trends 13.38. Key Developments 14. Middle East & Africa Modified Release Coatings Analysis 14.1. Key Findings 14.2. Middle East & Africa Modified Release Coatings Overview 14.3. Middle East & Africa Modified Release Coatings Value Share Analysis, By Polymer Type 14.4. Middle East & Africa Modified Release Coatings Forecast, By Polymer Type 14.4.1. Polyvinyl & Cellulose Acetate 14.4.2. Polyethylene Glycol (PEG) 14.4.3. Ethyl & Methyl Cellulose 14.4.4. Methacrylic Acid 14.4.5. Others 14.5. Middle East & Africa Modified Release Coatings Value Share Analysis, By Substrate Type 14.6. Middle East & Africa Modified Release Coatings Forecast, By Substrate Type 14.6.1. Tablets 14.6.2. Capsules 14.6.3. Pills 14.7. Middle East & Africa Modified Release Coatings Value Share Analysis, By Type 14.8. Middle East & Africa Modified Release Coatings Forecast, By Type 14.8.1. Sustained Modified Coatings 14.8.2. Enteric Coatings 14.9. Middle East & Africa Modified Release Coatings Value Share Analysis, by Country 14.10. Middle East & Africa Modified Release Coatings Forecast, by Country 14.10.1. GCC 14.10.2. South Africa 14.10.3. Rest of Middle East & Africa 14.11. Middle East & Africa Modified Release Coatings Analysis, by Country 14.12. GCC Modified Release Coatings Forecast, By Polymer Type 14.12.1. Polyvinyl & Cellulose Acetate 14.12.2. Polyethylene Glycol (PEG) 14.12.3. Ethyl & Methyl Cellulose 14.12.4. Methacrylic Acid 14.12.5. Others 14.13. GCC Modified Release Coatings Forecast, By Substrate Type 14.13.1. Tablets 14.13.2. Capsules 14.13.3. Pills 14.14. GCC Modified Release Coatings Forecast, By Type 14.14.1. Sustained Modified Coatings 14.14.2. Enteric Coatings 14.15. South Africa Modified Release Coatings Forecast, By Polymer Type 14.15.1. Polyvinyl & Cellulose Acetate 14.15.2. Polyethylene Glycol (PEG) 14.15.3. Ethyl & Methyl Cellulose 14.15.4. Methacrylic Acid 14.15.5. Others 14.16. South Africa Modified Release Coatings Forecast, By Substrate Type 14.16.1. Tablets 14.16.2. Capsules 14.16.3. Pills 14.17. South Africa Modified Release Coatings Forecast, By Type 14.17.1. Sustained Modified Coatings 14.17.2. Enteric Coatings 14.18. Rest of Middle East & Africa Modified Release Coatings Forecast, By Polymer Type 14.18.1. Polyvinyl & Cellulose Acetate 14.18.2. Polyethylene Glycol (PEG) 14.18.3. Ethyl & Methyl Cellulose 14.18.4. Methacrylic Acid 14.18.5. Others 14.19. Rest of Middle East & Africa Modified Release Coatings Forecast, By Substrate Type 14.19.1. Tablets 14.19.2. Capsules 14.19.3. Pills 14.20. Rest of Middle East &Africa Modified Release Coatings Forecast, By Type 14.20.1. Sustained Modified Coatings 14.20.2. Enteric Coatings 14.21. Middle East & Africa Modified Release Coatings Attractiveness Analysis 14.21.1. By Polymer Type 14.21.2. By Substrate Type 14.21.3. By Type 14.22. PEST Analysis 14.23. Key Trends 14.24. Key Developments 15. South America Modified Release Coatings Analysis 15.1. Key Findings 15.2. South America Modified Release Coatings Overview 15.3. South America Modified Release Coatings Value Share Analysis, By Polymer Type 15.4. South America Modified Release Coatings Forecast, By Polymer Type 15.4.1. Polyvinyl & Cellulose Acetate 15.4.2. Polyethylene Glycol (PEG) 15.4.3. Ethyl & Methyl Cellulose 15.4.4. Methacrylic Acid 15.4.5. Others 15.5. South America Modified Release Coatings Value Share Analysis, By Substrate Type 15.6. South America Modified Release Coatings Forecast, By Substrate Type 15.6.1. Tablets 15.6.2. Capsules 15.6.3. Pills 15.7. South America Modified Release Coatings Value Share Analysis, By Type 15.8. South America Modified Release Coatings Forecast, By Type 15.8.1. Sustained Modified Coatings 15.8.2. Enteric Coatings 15.9. South America Modified Release Coatings Value Share Analysis, by Country 15.10. South America Modified Release Coatings Forecast, by Country 15.10.1. Brazil 15.10.2. Mexico 15.10.3. Argentina 15.10.4. Rest of South America 15.11. South America Modified Release Coatings Analysis, by Country 15.12. Brazil Modified Release Coatings Forecast, By Polymer Type 15.12.1. Polyvinyl & Cellulose Acetate 15.12.2. Polyethylene Glycol (PEG) 15.12.3. Ethyl & Methyl Cellulose 15.12.4. Methacrylic Acid 15.12.5. Others 15.13. Brazil Modified Release Coatings Forecast, By Substrate Type 15.13.1. Tablets 15.13.2. Capsules 15.13.3. Pills 15.14. Brazil Modified Release Coatings Forecast, By Type 15.14.1. Sustained Modified Coatings 15.14.2. Enteric Coatings 15.15. Mexico Modified Release Coatings Forecast, By Polymer Type 15.15.1. Polyvinyl & Cellulose Acetate 15.15.2. Polyethylene Glycol (PEG) 15.15.3. Ethyl & Methyl Cellulose 15.15.4. Methacrylic Acid 15.15.5. Others 15.16. Mexico Modified Release Coatings Forecast, By Substrate Type 15.16.1. Tablets 15.16.2. Capsules 15.16.3. Pills 15.17. Mexico Modified Release Coatings Forecast, By Type 15.17.1. Sustained Modified Coatings 15.17.2. Enteric Coatings 15.18. ArgentinaModified Release Coatings Forecast, By Polymer Type 15.18.1. Polyvinyl & Cellulose Acetate 15.18.2. Polyethylene Glycol (PEG) 15.18.3. Ethyl & Methyl Cellulose 15.18.4. Methacrylic Acid 15.18.5. Others 15.19. Argentina Modified Release Coatings Forecast, By Substrate Type 15.19.1. Tablets 15.19.2. Capsules 15.19.3. Pills 15.20. Argentina Modified Release Coatings Forecast, By Type 15.20.1. Sustained Modified Coatings 15.20.2. Enteric Coatings 15.21. Rest of South America Modified Release Coatings Forecast, By Polymer Type 15.21.1. Polyvinyl & Cellulose Acetate 15.21.2. Polyethylene Glycol (PEG) 15.21.3. Ethyl & Methyl Cellulose 15.21.4. Methacrylic Acid 15.21.5. Others 15.22. Rest of South America Modified Release Coatings Forecast, By Substrate Type 15.22.1. Tablets 15.22.2. Capsules 15.22.3. Pills 15.23. Rest of South America Modified Release Coatings Forecast, By Type 15.23.1. Sustained Modified Coatings 15.23.2. Enteric Coatings 15.24. South America Modified Release Coatings Attractiveness Analysis 15.24.1. By Polymer Type 15.24.2. By Substrate Type 15.24.3. By Type 15.25. PEST Analysis 15.26. Key Trends 15.27. Key Developments 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Applications 16.2.3.2. M&A Key Players, Forward Integration and BackwardIntegration 16.3. Company Profiles: Key Players 16.3.1. Teva Pharmaceutical Industries Ltd 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Product Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Development Footprint 16.3.2. Valeant Pharmaceuticals International, Inc 16.3.3. Sun Pharmaceutical Industries Ltd 16.3.4. Evonik Industries AG 16.3.5. Coating Place, Inc 16.3.6. GlaxoSmithKline plc 16.3.7. Corium International, Inc 16.3.8. Orbis Biosciences, Inc 16.3.9. Mylan N.V 16.3.10. Pfizer, Inc 16.3.11. Evonik 16.3.12. Colorcon 16.3.13. BASF SE 16.3.14. Novartis AG 16.3.15. AstraZeneca 16.3.16. Depomed, Inc 17. Primary Key Insights